Department of Healthcare Economics

ARALAST AATmosphere

Call on our team of personal advocates to support Alphas and their families at ARALAST AATmosphere.

Alpha1Health.com Survey

Take our survey to help us best meet the needs of the Alpha-1 community.

Do you have a question about reimbursement for ARALAST?

The Department of Healthcare Economics can help you find answers.

Baxter's Department of Healthcare Economics has expertise in assisting healthcare providers, patients, and payors with a variety of economic, insurance, and reimbursement-related issues.

Our Department of Healthcare Economics:

Provides coverage, support, and assistance with challenging issues
Coordinates patient assistance programs
Offers patient education programs and advocacy for insurance-related concerns
Facilitates gathering technical and clinical information for medical professionals
Analyzes and disseminates healthcare economics information to customers upon request

These services are available to Alpha-1 patients at no charge. Call the Department of Healthcare Economics (1-800-968-9937) for more information.

Do you belong to an Alpha-1 support group? Invite an HCE representative to speak at a meeting. Our HCE representatives can help your group understand the maze of insurance issues.

To request an HCE guest speaker contact us.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

To view PDF, you will need Adobe® Acrobat® Reader® software.